The Netherlands
Praxa Sense, founded in 2018, is innovating within the remote monitoring industry with their patented technology, the ALIS speckle sensor. This company is dedicated to elevating healthcare standards by providing precise and reliable data, regardless of user movement or skin tone variances.
Notably, their laser speckle-sensor addresses significant drawbacks of conventional remote monitoring devices. Key benefits include robust signal stability during motion, accurate performance on darker skin tones, and the ability to measure additional biomarkers like blood pressure, setting their product apart from traditional options.
Based on the latest financial update, Praxa Sense secured a modest €1.50K Support Program investment on 01 October 2020. This funding round attracted interest from EIT Health, highlighting industry recognition of their potential.
Though currently lacking a specific headquarters, Praxa Sense remains a promising player in the med-tech space, poised to make substantial contributions to future healthcare solutions.
